Effect of COVID-19 on neuromotor development of infants: A case control study

Emine Tekin; Handan Ayhan Akoğlu; Muhammet Bulut; Fuat Sönmez; Mintaze Kerem Günel

Makale detayları

Effect of COVID-19 on neuromotor development of infants: A case control study

Yazarlar:

Emine Tekin | Handan Ayhan Akoğlu | Muhammet Bulut | Fuat Sönmez | Mintaze Kerem Günel

Yayıncı:

Ondokuz Mayıs University

Ana Başlıklar:

Health Care Administration

Dergi:

Deneysel ve Klinik Tıp Dergisi Vol.40 Issue 4, pp.703-709

Belge Tipi:

Makale

Yayın Tarihi:

3/2024

Belge Dili:

İngilizce

Document ID (Org No.):

2001302830

pISSN:

1309-4483

Anahtar kelimeler:

Özet:

 Effects of the COVID-19 pandemic on neuromotor development of infants is not clear yet. In this study, based on the hypothesis that COVID-19 may cause delay in neuromotor development in infants, it was aimed to evaluate and compare the neuromotor development of 6-18 month-old infants who were hospitalized for COVID-19 and healthy children. All of the children were assessed at one point by the pediatric neurologist and pediatric physiotherapist. The Denver II developmental screening test DDST, Hammersmith Infant Neurological Examination HINE test, and Alberta Infant Motor Scale AIMS were used to determine the neurodevelopmental status of the infants. SARS-CoV-2 PCR positive 27 children 14 boys, 13 girls and 29 healthy children 15 boys, 14 girls were included in the study. The clinical findings of most of the patients were mild. The mean age of the patients was 11.44.2 months and the mean length of hospital stay was 4.62.4 days. The most common symptom was fever in 19 patients 70 followed by cough 25.9, diarrhea 25.9, vomiting 18.5, loss of appetite 14.8, myalgia 11.1, dyspnea 3.7, and sore throat 3.7. No significant feature was detected in laboratory and imaging findings. The DDST was abnormal in 3 COVID patients: one of them was a 6-month-old patient with a birth history of asphyxia and the others were age-retarded in language and social development with no chronic disease. There was no significant difference in the HINE and AIMS tests. In small-scale and short-term follow-up, we found that COVID-19 did not inhibit the neuromotor development of infants except for slight retardation in language and social development. We think there is a need for more comprehensive prospective studies including patients with moderate and severe infections.

 Effects of the COVID-19 pandemic on neuromotor development of infants is not clear yet. In this study, based on the hypothesis that COVID-19 may cause delay in neuromotor development in infants, it was aimed to evaluate and compare the neuromotor development of 6-18 month-old infants who were hospitalized for COVID-19 and healthy children. All of the children were assessed at one point by the pediatric neurologist and pediatric physiotherapist. The Denver II developmental screening test DDST, Hammersmith Infant Neurological Examination HINE test, and Alberta Infant Motor Scale AIMS were used to determine the neurodevelopmental status of the infants. SARS-CoV-2 PCR positive 27 children 14 boys, 13 girls and 29 healthy children 15 boys, 14 girls were included in the study. The clinical findings of most of the patients were mild. The mean age of the patients was 11.44.2 months and the mean length of hospital stay was 4.62.4 days. The most common symptom was fever in 19 patients 70 followed by cough 25.9, diarrhea 25.9, vomiting 18.5, loss of appetite 14.8, myalgia 11.1, dyspnea 3.7, and sore throat 3.7. No significant feature was detected in laboratory and imaging findings. The DDST was abnormal in 3 COVID patients: one of them was a 6-month-old patient with a birth history of asphyxia and the others were age-retarded in language and social development with no chronic disease. There was no significant difference in the HINE and AIMS tests. In small-scale and short-term follow-up, we found that COVID-19 did not inhibit the neuromotor development of infants except for slight retardation in language and social development. We think there is a need for more comprehensive prospective studies including patients with moderate and severe infections.

 Effects of the COVID-19 pandemic on neuromotor development of infants is not clear yet. In this study, based on the hypothesis that COVID-19 may cause delay in neuromotor development in infants, it was aimed to evaluate and compare the neuromotor development of 6-18 month-old infants who were hospitalized for COVID-19 and healthy children. All of the children were assessed at one point by the pediatric neurologist and pediatric physiotherapist. The Denver II developmental screening test DDST, Hammersmith Infant Neurological Examination HINE test, and Alberta Infant Motor Scale AIMS were used to determine the neurodevelopmental status of the infants. SARS-CoV-2 PCR positive 27 children 14 boys, 13 girls and 29 healthy children 15 boys, 14 girls were included in the study. The clinical findings of most of the patients were mild. The mean age of the patients was 11.44.2 months and the mean length of hospital stay was 4.62.4 days. The most common symptom was fever in 19 patients 70 followed by cough 25.9, diarrhea 25.9, vomiting 18.5, loss of appetite 14.8, myalgia 11.1, dyspnea 3.7, and sore throat 3.7. No significant feature was detected in laboratory and imaging findings. The DDST was abnormal in 3 COVID patients: one of them was a 6-month-old patient with a birth history of asphyxia and the others were age-retarded in language and social development with no chronic disease. There was no significant difference in the HINE and AIMS tests. In small-scale and short-term follow-up, we found that COVID-19 did not inhibit the neuromotor development of infants except for slight retardation in language and social development. We think there is a need for more comprehensive prospective studies including patients with moderate and severe infections.

 Effects of the COVID-19 pandemic on neuromotor development of infants is not clear yet. In this study, based on the hypothesis that COVID-19 may cause delay in neuromotor development in infants, it was aimed to evaluate and compare the neuromotor development of 6-18 month-old infants who were hospitalized for COVID-19 and healthy children. All of the children were assessed at one point by the pediatric neurologist and pediatric physiotherapist. The Denver II developmental screening test DDST, Hammersmith Infant Neurological Examination HINE test, and Alberta Infant Motor Scale AIMS were used to determine the neurodevelopmental status of the infants. SARS-CoV-2 PCR positive 27 children 14 boys, 13 girls and 29 healthy children 15 boys, 14 girls were included in the study. The clinical findings of most of the patients were mild. The mean age of the patients was 11.44.2 months and the mean length of hospital stay was 4.62.4 days. The most common symptom was fever in 19 patients 70 followed by cough 25.9, diarrhea 25.9, vomiting 18.5, loss of appetite 14.8, myalgia 11.1, dyspnea 3.7, and sore throat 3.7. No significant feature was detected in laboratory and imaging findings. The DDST was abnormal in 3 COVID patients: one of them was a 6-month-old patient with a birth history of asphyxia and the others were age-retarded in language and social development with no chronic disease. There was no significant difference in the HINE and AIMS tests. In small-scale and short-term follow-up, we found that COVID-19 did not inhibit the neuromotor development of infants except for slight retardation in language and social development. We think there is a need for more comprehensive prospective studies including patients with moderate and severe infections.

Makale detayları

Effect of COVID-19 on neuromotor development of infants: A case control study

Yazarlar:

Emine Tekin | Handan Ayhan Akoğlu | Muhammet Bulut | Fuat Sönmez | Mintaze Kerem Günel

Yayıncı:

Ondokuz Mayıs University

Ana Başlıklar:

Health Care Administration

Dergi:

Deneysel ve Klinik Tıp Dergisi Vol.40 Issue 4, pp.703-709

Belge Tipi:

Makale

Yayın Tarihi:

3/2024

Belge Dili:

İngilizce

Document ID (Org No.):

2001302830

pISSN:

1309-4483

COVID-19

Denver II developmental scale

Hammersmith Infant Neurological Examination

neuromotor development

Alberta ınfant motor scale

Sayı

Makale detayları

Effect of COVID-19 on neuromotor development of infants: A case control study

Yazarlar: Emine Tekin | Handan Ayhan Akoğlu | Muhammet Bulut | Fuat Sönmez | Mintaze Kerem Günel

Yayıncı: Ondokuz Mayıs University

Ana Başlıklar: Health Care Administration

Dergi: Deneysel ve Klinik Tıp Dergisi Vol.40 Issue 4, pp.703-709

Belge Tipi: Makale

Yayın Tarihi: 3/2024

Belge Dili: İngilizce

Document ID (Org No.): 2001302830

pISSN: 1309-4483

COVID-19

Denver II developmental scale

Hammersmith Infant Neurological Examination

neuromotor development

Alberta ınfant motor scale

Sayı

Yazarlar:

Emine Tekin | Handan Ayhan Akoğlu | Muhammet Bulut | Fuat Sönmez | Mintaze Kerem Günel

Yayıncı:

Ondokuz Mayıs University

Ana Başlıklar:

Health Care Administration

Dergi:

Deneysel ve Klinik Tıp Dergisi Vol.40 Issue 4, pp.703-709

Belge Tipi:

Makale

Yayın Tarihi:

3/2024

Belge Dili:

İngilizce

Document ID (Org No.):

2001302830

pISSN:

1309-4483